FR2812548B1 - Utilisation de derives de quinolein-2(1h)-one ou un de leurs sels pharmaceutiquement acceptable pour la preparation d'un medicament destine au traitement de l'insuffisance renale - Google Patents

Utilisation de derives de quinolein-2(1h)-one ou un de leurs sels pharmaceutiquement acceptable pour la preparation d'un medicament destine au traitement de l'insuffisance renale

Info

Publication number
FR2812548B1
FR2812548B1 FR0010136A FR0010136A FR2812548B1 FR 2812548 B1 FR2812548 B1 FR 2812548B1 FR 0010136 A FR0010136 A FR 0010136A FR 0010136 A FR0010136 A FR 0010136A FR 2812548 B1 FR2812548 B1 FR 2812548B1
Authority
FR
France
Prior art keywords
quinolein
derivatives
preparation
treatment
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0010136A
Other languages
English (en)
Other versions
FR2812548A1 (fr
Inventor
Philip Janiak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Priority to FR0010136A priority Critical patent/FR2812548B1/fr
Priority to PCT/FR2001/002493 priority patent/WO2002009712A1/fr
Priority to AU2001279933A priority patent/AU2001279933A1/en
Publication of FR2812548A1 publication Critical patent/FR2812548A1/fr
Application granted granted Critical
Publication of FR2812548B1 publication Critical patent/FR2812548B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0010136A 2000-08-01 2000-08-01 Utilisation de derives de quinolein-2(1h)-one ou un de leurs sels pharmaceutiquement acceptable pour la preparation d'un medicament destine au traitement de l'insuffisance renale Expired - Fee Related FR2812548B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0010136A FR2812548B1 (fr) 2000-08-01 2000-08-01 Utilisation de derives de quinolein-2(1h)-one ou un de leurs sels pharmaceutiquement acceptable pour la preparation d'un medicament destine au traitement de l'insuffisance renale
PCT/FR2001/002493 WO2002009712A1 (fr) 2000-08-01 2001-07-31 Utilisation de derives de quinolein-2(1h)-one pour le traitement de l'insuffisance renale
AU2001279933A AU2001279933A1 (en) 2000-08-01 2001-07-31 Use of quinoline-2(1h)-one derivatives for treating renal disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0010136A FR2812548B1 (fr) 2000-08-01 2000-08-01 Utilisation de derives de quinolein-2(1h)-one ou un de leurs sels pharmaceutiquement acceptable pour la preparation d'un medicament destine au traitement de l'insuffisance renale

Publications (2)

Publication Number Publication Date
FR2812548A1 FR2812548A1 (fr) 2002-02-08
FR2812548B1 true FR2812548B1 (fr) 2002-09-20

Family

ID=8853192

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0010136A Expired - Fee Related FR2812548B1 (fr) 2000-08-01 2000-08-01 Utilisation de derives de quinolein-2(1h)-one ou un de leurs sels pharmaceutiquement acceptable pour la preparation d'un medicament destine au traitement de l'insuffisance renale

Country Status (3)

Country Link
AU (1) AU2001279933A1 (fr)
FR (1) FR2812548B1 (fr)
WO (1) WO2002009712A1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK167187A (da) * 1986-04-02 1987-10-03 Otsuka Pharma Co Ltd Carbostyrilderivater og salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse
ES2138092T3 (es) * 1993-10-21 2000-01-01 Otsuka Pharma Co Ltd Utilizacion de los derivados de carbostirilo para la obtencion de un medicamento destinado para inhibir la produccion de la interleucina-8.
CN1094490C (zh) * 1995-09-15 2002-11-20 圣诺菲合成实验室公司 作为血清素拮抗剂的喹诺－2(1h)－酮衍生物

Also Published As

Publication number Publication date
WO2002009712A1 (fr) 2002-02-07
AU2001279933A1 (en) 2002-02-13
FR2812548A1 (fr) 2002-02-08

Similar Documents

Publication Publication Date Title
FR2806918B1 (fr) Catheter pour l'administration specifique d'un medicament
FR2761266B1 (fr) Composition pharmaceutique formee par granulation humide pour l'administration orale d'un derive du n-piperidino-3- pyrazolecarboxamide, de ses sels et de leurs solvates
DE60235719D1 (de) Frauenhygieneartikel zur verabreichung von arzneimittel
DZ3358A1 (fr) Formulations en solution pharmaceutiques pour inhalateurs-doseurs sous pression
MA26790A1 (fr) Composition dietetique ou pharmaceutique a l'usage pour la prevention ou le traitement de la hyper-oxalurie
MA26842A1 (fr) Amino-acides bicycliques servant d'agents pharmaceutiques
LU91651I2 (fr) Produits médicinaux contenent de l'indacatérol ou un sel de celui-ci (ONBREZ BREEZHALER®)
AU2001230892A1 (en) Orally administered pharmaceutical formulations of benzimidazole derivatives andthe method of preparing the same
LU92826I2 (fr) Lubiprostone, incluant les sels pharmaceutiquementacceptables, les esters ou les amides de la lubip rostone
BR0109650A (pt) 3-cianoquinolinas, 3-ciano-1,6-naftiridinas e 3-ciano-1,7-naftiridinas como inibidores da cinase proteìca
HUP0200895A3 (en) Benzimidazole derivatives of alpha-substituted carboxylic acids, pharmaceutical compositions containing them and their use
NO2013004I2 (no) Axitinib, valgfritt i form av et farmasøytisk aksentabelt salt
FR2867778B1 (fr) Utilisation de derives d'indazolecarboxamides pour la preparation d'un medicament destine au traitement et a la prevention du paludisme
MA26456A1 (fr) Formulations pharmaceutiques pour la distribution prolongee de medicament.
FR2808685B1 (fr) Compositions pharmaceutiques pour administration transdermique d'agents anti-inflammatoires
TNSN00108A1 (fr) Derives d'erythromycine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
DZ3014A1 (fr) Médicaments pour le traitement de l'hypertension.
MA26230A1 (fr) Agents antidysrythmiques administres par voie vaginale utilises pour traiter les douleurs pelviennes et la sterilite
FR2809310B1 (fr) Utilisation de derives de biguanide pour fabriquer un medicament ayant un effet cicatrisant
EE200100422A (et) Epotilooni derivaadid, nende valmistamismeetod jafarmatseutiline kasutamine
FR2788696B1 (fr) Utilisation de derives de pyridazino [4,5-b] indole-1-acetamide pour la preparation de medicaments destines aux maladies du systeme nerveux central
HUP0002963A3 (en) Use of pyrazolo-[4,3-d] pyrimidinon derivatives for the production of pharmaceutical compositions for treating diseases of the eye field
DZ2743A1 (fr) Sels de cetoacides et de dérivés amines et leur utilisation pour la preparation de medicaments.
FR2798755B1 (fr) Systeme d'administration pour machines multimodulaires multiprocesseurs
HUP0102159A3 (en) Pharmaceutical composition for the treatment of rumen acidosis

Legal Events

Date Code Title Description
ST Notification of lapse